GZBL(SZ:002424) Zhong Guo Jing Ying Bao·2025-12-03 15:09Group 1 - The actual controller of Guizhou Bailing, Jiang Wei, has been investigated by the China Securities Regulatory Commission (CSRC) for insider trading, illegal information disclosure, and violations related to stock transfer restrictions [2][3] - Guizhou Bailing stated that the investigation is focused on Jiang Wei personally and is unrelated to the company's daily operations or business activities, indicating no impact on the company's production and management [3] - A year prior, Guizhou Bailing was also investigated by the CSRC for illegal information disclosure, highlighting ongoing regulatory scrutiny [4] Group 2 - As of December 3, 2025, Guizhou Bailing has a total market capitalization of approximately 7.785 billion yuan [4] - The company reported a revenue of 2.1 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 24.28%, and a net profit attributable to shareholders of 57 million yuan, down 35.6% year-on-year [4] - Guizhou Bailing's main products include exclusive苗药 (Miao medicine) products such as Yindan Xinnaotong soft capsules, Kesu Ting syrup and capsules, and non-Miao medicine products like Jingan capsules and Vitamin C Yinqiao tablets [4]